Philip Imus

1.6k total citations
40 papers, 583 citations indexed

About

Philip Imus is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Philip Imus has authored 40 papers receiving a total of 583 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Hematology, 13 papers in Oncology and 10 papers in Immunology. Recurrent topics in Philip Imus's work include Hematopoietic Stem Cell Transplantation (15 papers), Multiple Myeloma Research and Treatments (8 papers) and Renal Transplantation Outcomes and Treatments (6 papers). Philip Imus is often cited by papers focused on Hematopoietic Stem Cell Transplantation (15 papers), Multiple Myeloma Research and Treatments (8 papers) and Renal Transplantation Outcomes and Treatments (6 papers). Philip Imus collaborates with scholars based in United States, Sweden and Germany. Philip Imus's co-authors include Richard J. Jones, Ivan Borrello, Amy E. DeZern, Kenneth R. Cooke, Lode J. Swinnen, Ephraim J. Fuchs, Richard F. Ambinder, Douglas E. Gladstone, Syed Abbas Ali and Nina D. Wagner‐Johnston and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Philip Imus

35 papers receiving 575 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip Imus United States 12 361 231 220 94 66 40 583
Shannon R. McCurdy United States 17 602 1.7× 219 0.9× 266 1.2× 150 1.6× 70 1.1× 70 737
Laura Bellio Italy 10 203 0.6× 186 0.8× 142 0.6× 53 0.6× 66 1.0× 15 508
Anna Pawłowska United States 11 125 0.3× 95 0.4× 129 0.6× 35 0.4× 124 1.9× 44 465
Samer K. Khaled United States 20 589 1.6× 198 0.9× 208 0.9× 165 1.8× 240 3.6× 65 950
Liliane Dal Cortivo France 11 396 1.1× 176 0.8× 326 1.5× 34 0.4× 107 1.6× 19 670
HM Lazarus United States 6 305 0.8× 143 0.6× 71 0.3× 156 1.7× 89 1.3× 7 461
Howard R. Terebelo United States 14 473 1.3× 309 1.3× 93 0.4× 114 1.2× 312 4.7× 74 716
Marcello Rotta United States 13 631 1.7× 295 1.3× 168 0.8× 59 0.6× 314 4.8× 29 756
Ryan Jacobs United States 12 182 0.5× 176 0.8× 113 0.5× 93 1.0× 26 0.4× 59 505
Muthalagu Ramanathan United States 11 243 0.7× 103 0.4× 102 0.5× 37 0.4× 66 1.0× 53 390

Countries citing papers authored by Philip Imus

Since Specialization
Citations

This map shows the geographic impact of Philip Imus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Imus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Imus more than expected).

Fields of papers citing papers by Philip Imus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Imus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Imus. The network helps show where Philip Imus may publish in the future.

Co-authorship network of co-authors of Philip Imus

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Imus. A scholar is included among the top collaborators of Philip Imus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Imus. Philip Imus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
DeZern, Amy E., Marianna Zahurak, Heather J. Symons, et al.. (2025). Long-Term Follow-Up of the Baltimore Experience with Hematopoietic Cell Transplantation for Severe Aplastic Anemia Using Post-Transplantation Cyclophosphamide. Transplantation and Cellular Therapy. 32(3). 310–319.
2.
Gocke, Christian B., Christopher D. Gocke, Syed Abbas Ali, et al.. (2025). Lenalidomide-associated reversible TP53-mutated clonal hematopoiesis in plasma cell neoplasms. Haematologica. 111(2). 760–763.
3.
Gerber, Gloria F., et al.. (2024). Management of patients with concurrent clonal plasma cell and myeloid disorders: A single center descriptive case series. Leukemia Research Reports. 22. 100469–100469.
4.
Imus, Philip, Sergiu Paşca, Hua‐Ling Tsai, et al.. (2024). Recipient clonal hematopoiesis in allogeneic bone marrow transplantation for lymphoid malignancies. Blood Advances. 8(14). 3849–3858. 4 indexed citations
5.
6.
DeZern, Amy E., Marianna Zahurak, Heather J. Symons, et al.. (2023). Alternative donor BMT with post-transplant cyclophosphamide as initial therapy for acquired severe aplastic anemia. Blood. 141(25). 3031–3038. 18 indexed citations
7.
Ghiaur, Gabriel, et al.. (2023). Bone marrow niche chemoprotection of metastatic solid tumors mediated by CYP3A4. Cancer. 129(11). 1744–1751. 6 indexed citations
8.
9.
Thornton, Clifton P., Karen Bandeen‐Roche, Laken Roberts, et al.. (2023). Clinical trial participation predicts improved survival in older adults receiving allogeneic blood and marrow transplant. BMC Geriatrics. 23(1). 120–120. 3 indexed citations
10.
Tsai, Hua‐Ling, Ephraim J. Fuchs, Lode J. Swinnen, et al.. (2022). Allogeneic Blood or Marrow Transplantation with Post-Transplantation Cyclophosphamide for Peripheral T Cell Lymphoma: The Importance of Graft Source. Transplantation and Cellular Therapy. 29(4). 267.e1–267.e5. 6 indexed citations
11.
Huff, Carol Ann, Anna Ferguson, Lakshmi Rudraraju, et al.. (2021). An Allogeneic Multiple Myeloma GM-CSF–Secreting Vaccine with Lenalidomide Induces Long-term Immunity and Durable Clinical Responses in Patients in Near Complete Remission. Clinical Cancer Research. 27(24). 6696–6708. 12 indexed citations
12.
DeZern, Amy E., Hua‐Ling Tsai, Philip Imus, et al.. (2021). Relationship of donor age and relationship to outcomes of haploidentical transplantation with posttransplant cyclophosphamide. Blood Advances. 5(5). 1360–1368. 53 indexed citations
13.
DeZern, Amy E., et al.. (2021). The Art of Donor Selection: Donor Age and Relationship in NMA Haplo BMT. Transplantation and Cellular Therapy. 27(3). S240–S240. 1 indexed citations
14.
Zahurak, Marianna, Maria Bettinotti, Syed Abbas Ali, et al.. (2021). Nonmyeloablative, HLA-Mismatched Unrelated Peripheral Blood Transplantation with High-Dose Post-Transplantation Cyclophosphamide. Transplantation and Cellular Therapy. 27(11). 909.e1–909.e6. 10 indexed citations
15.
Sidhom, John-William, Amy S. Duffield, Michael B. Streiff, et al.. (2021). Deep learning for diagnosis of acute promyelocytic leukemia via recognition of genomically imprinted morphologic features. npj Precision Oncology. 5(1). 38–38. 21 indexed citations
16.
Greenberg, Ross S., Jake A. Ruddy, Brian J. Boyarsky, et al.. (2021). Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with multiple myeloma. BMC Cancer. 21(1). 1354–1354. 11 indexed citations
17.
DeZern, Amy E., Hany Elmariah, Marianna Zahurak, et al.. (2020). Shortened-Duration Immunosuppressive Therapy after Nonmyeloablative, Related HLA-Haploidentical or Unrelated Peripheral Blood Grafts and Post-Transplantation Cyclophosphamide. Biology of Blood and Marrow Transplantation. 26(11). 2075–2081. 22 indexed citations
18.
Imus, Philip, Hua-Ling Tsai, Amy E. DeZern, et al.. (2020). Thrombotic Microangiopathy after Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis. Biology of Blood and Marrow Transplantation. 26(12). 2306–2310. 7 indexed citations
19.
Imus, Philip, Amanda L. Blackford, Maria Bettinotti, et al.. (2019). Severe Cytokine Release Syndrome after Haploidentical Peripheral Blood Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 25(12). 2431–2437. 56 indexed citations
20.
Markowski, Mark C., et al.. (2017). Long-Term Control of Oligometastatic Prostate Cancer After Stereotactic Body Radiotherapy in the Absence of Androgen Deprivation Therapy: A Case Report. Clinical Genitourinary Cancer. 15(5). e839–e842. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shannon R. McCurdy Breakdown of academic impact, for papers by Laura Bellio Breakdown of academic impact, for papers by Anna Pawłowska Breakdown of academic impact, for papers by Samer K. Khaled Breakdown of academic impact, for papers by Liliane Dal Cortivo Breakdown of academic impact, for papers by HM Lazarus Breakdown of academic impact, for papers by Howard R. Terebelo Breakdown of academic impact, for papers by Marcello Rotta Breakdown of academic impact, for papers by Ryan Jacobs Breakdown of academic impact, for papers by Muthalagu Ramanathan
Rankless by CCL
2026